GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
P

Pell Bio Med Technology Co 6949.TW · TWD

N/A · Taiwan Stock Exchange · 🇹🇼 Taiwan

Compare

40.05

+6.66%

Close of 9 Nov 2026, in TWD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in TWD, from our data supplier.

FY2025

Revenue

TWD 31.4m

FY2021FY2025

Net income

−TWD 423.9m

FY2021FY2025

Free cash flow

−TWD 508.9m

FY2021FY2025

Shareholders' equity

TWD 1.42bn

FY2021FY2025

Income statement

Fiscal years

FY2025FY2024FY2023FY2022FY2021
RevenueTWD 31.4mTWD 19.6mTWD 18.0mTWD 17.2mTWD 14.0m
Research and developmentTWD 252.7mTWD 266.2mTWD 239.6mTWD 142.4mTWD 136.7m
Operating income−TWD 467.4m−TWD 413.5m−TWD 411.2m−TWD 236.1m−TWD 196.0m
Net income−TWD 423.9m−TWD 389.4m−TWD 398.8m−TWD 230.1m−TWD 189.0m
Diluted earnings per share-7.20-6.74-7.79-5.21-5.68

Balance sheet

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021
Total assetsTWD 2.11bnTWD 1.74bnTWD 1.42bnTWD 1.04bnTWD 393.9m
Cash and short-term investmentsTWD 1.31bnTWD 1.14bnTWD 1.11bnTWD 708.4mTWD 115.8m
Total liabilitiesTWD 418.3mTWD 458.6mTWD 236.8mTWD 229.8mTWD 169.0m
DebtTWD 128.1mTWD 365.0mTWD 173.0mTWD 202.6mTWD 135.6m
Shareholders' equityTWD 1.42bnTWD 1.18bnTWD 1.17bnTWD 800.9mTWD 224.9m
Shares outstanding59m58m51m44m33m

Cash flow

Fiscal years

FY2025FY2024FY2023FY2022FY2021
Cash from operations−TWD 281.3m−TWD 260.1m−TWD 180.0m−TWD 155.7m−TWD 108.5m
Capital spending−TWD 227.6m−TWD 264.0m−TWD 16.5m−TWD 8.5m−TWD 14.5m
Free cash flow−TWD 508.9m−TWD 524.1m−TWD 196.5m−TWD 164.2m−TWD 123.0m

Latest quarters

By quarter end

Jun 2026Mar 2026Dec 2025Sept 2025Jun 2025Mar 2025Dec 2024Sept 2024
RevenueTWD 8.9mTWD 6.4mTWD 6.1mTWD 7.5mTWD 5.9mTWD 11.9mTWD 4.6mTWD 5.0m
Operating income−TWD 109.3m−TWD 88.8m−TWD 174.2m−TWD 125.3m−TWD 83.0m−TWD 84.8m−TWD 107.0m−TWD 106.2m
Net income−TWD 100.4m−TWD 76.6m−TWD 167.2m−TWD 118.4m−TWD 77.8m−TWD 75.8m−TWD 101.7m−TWD 100.8m
Diluted earnings per share-1.53-1.17-2.84-2.01-1.32-1.29-1.76-1.75
Cash from operations—−TWD 113.0m−TWD 82.0m−TWD 75.0m−TWD 63.0m−TWD 59.0m−TWD 69.0m−TWD 94.0m
Capital spending—−TWD 54.0m−TWD 72.0m−TWD 77.0m−TWD 26.0m−TWD 51.0m−TWD 148.0m−TWD 114.0m
Free cash flow—−TWD 167.0m−TWD 154.0m−TWD 152.0m−TWD 89.0m−TWD 110.0m−TWD 217.0m−TWD 208.0m
Total assets—TWD 3.29bnTWD 2.11bnTWD 1.62bnTWD 1.66bnTWD 1.68bnTWD 1.74bnTWD 1.62bn
Cash and short-term investments—TWD 2.45bnTWD 1.31bnTWD 920.2mTWD 961.5mTWD 1.03bnTWD 1.14bnTWD 1.21bn
Debt—TWD 129.9mTWD 128.1mTWD 127.9mTWD 227.8mTWD 227.7mTWD 227.6mTWD 54.9m
Shareholders' equity—TWD 2.66bnTWD 1.42bnTWD 957.2mTWD 1.04bnTWD 1.12bnTWD 1.18bnTWD 1.27bn

Financial ratios

Data as of 19 Sept 2026

FY2025FY2024FY2023FY2022FY2021
Operating margin-1487.2%-2106.3%-2280.5%-1376.2%-1402.0%
Net margin-1349.1%-1983.7%-2211.3%-1341.3%-1351.9%
Return on equity-29.8%-33.0%-34.1%-28.7%-84.0%
Return on assets-20.1%-22.3%-28.1%-22.0%-48.0%
Free cash flow yield-0.1%0.1%-5.7%-6.0%—
Revenue growth60.1%8.9%5.1%22.8%—
Earnings growth8.9%-2.3%73.3%21.8%—
Current ratio4.31x3.60x12.62x12.67x2.98x
Debt to equity0.09x0.19x0.02x0.04x0.11x
Equity ratio67.3%67.6%82.5%76.7%57.1%
Interest coverage-228.53x-182.96x-160.89x-173.48x-129.09x
R&D as a share of sales804.0%1355.8%1328.8%829.8%978.1%
Buybacks as a share of market value-1937.4%-12.8%-16.0%——

Growth per year

Compound annual rate

3 years5 years10 years
Revenue23.0%——
Operating income25.6%——
Net income22.6%——

Valuation history

At each fiscal year end

FY2025FY2024
Price to earnings-47.5-12.1
Price to sales—271.7

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.